1. In Vivo
  2. >>ESG
  3. >>Diversity & Inclusion

The Pharma Skills-Based Economy Emerges

The Great Resignation Has Catalyzed The Drive To Ditch The University Degree In Favor Of Skills And Values

 
• By Jo Shorthouse

Resetting requirements for jobs, with the importance of degrees and higher education lessened in favor of appropriate skills and talent, is a trend that could hugely benefit both employers and staff over the next ten years, creating a skills-based economy in which all members can thrive to counter the Great Resignation.    

Hiring
Skills-based hiring results in a more varied talent pool • Source: Shutterstock

How we hire can be limiting. Many recruiters look firstly for a degree-level education and previous experience in the field. The global pandemic has caused many workers to lose their jobs in hospitality and travel, for example, while some employers couldn’t hire quickly enough to fill gaps in their workforce that may have been displaced, or chosen to relocate, post-COVID.

LinkedIn has reported a 21% increase over the past year in US job postings that advertise skills and responsibilities instead...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diversity & Inclusion

RESILIENCE Initiative Navigates The World Of Making Medicines Through VR Technology

 
• By Anabel Costa-Ferreira

The process of manufacturing medicines can often be complex, expensive and harmful to the environment. Initiatives like RESILIENCE UK are seeking to simplify this process, utilizing VR technology to create a more sustainable learning environment for both students and companies.

Cracking Through ‘The Bamboo Ceiling’: East Asians Reach For Pharma Leadership

 
• By Brian Yang

Despite the significant presence of East Asian professionals in the pharmaceutical industry, their representation in top leadership roles remains disproportionately low. This disparity can be attributed to cultural bias, limited access to influential networks, and systemic barriers within corporate structures.

Infographic: Analyzing The Gap In Women’s Health Care

 
• By Anabel Costa-Ferreira

Looking at a recent McKinsey report alongside our Evaluate data, the below infographic provides insight into the investment scene of pharma and raises questions as to how the industry is seemingly yet to seize the opportunity in women's health.

Growing Calls For Labelling Changes With Obesity Patients In Mind

 
• By Ed Silverman

Despite significant investments in weight loss treatments, pharmaceutical companies face criticism for neglecting to study their drugs in obese patients, possibly leading to incomplete labeling and patient risks, prompting calls for the FDA to enforce more inclusive clinical trials and updated drug information.

More from ESG

Global Regulator Action To Improve Diversity In Clinical Trials

 
• By Vibha Sharma

As efforts to improve diversity in clinical trials gain momentum globally, regulators in the UK, the EU, Canada, Australia and Japan were asked about their efforts to support representative enrolment. 

Providing The Balance Between Medtech Innovation And Providers’ Sustainability

 
• By Ashley Yeo

Royal Philips is at the forefront of the driving environmental sustainability along the Scope 1-2-3 chain. The company hosted a round table in Amsterdam to hear experiences from providers.

FDA Publishes Updated Roadmap For Advancing Women’s Health

 
• By Brian Bossetta

The US FDA’s Office of Women’s Health provides a research roadmap to address health concerns specific to women. The FDA recently updated the roadmap, outlining areas in which further research is needed.